Cargando…

Social Determinants of Health Data Improve the Prediction of Cardiac Outcomes in Females with Breast Cancer

SIMPLE SUMMARY: This research aimed to investigate if adding social determinants of health (SDOH) to predictive models improves major adverse cardiovascular events (MACE) predictions in breast cancer patients, as cardiovascular disease is their leading cause of death. ML models, incorporating SDOH,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stabellini, Nickolas, Cullen, Jennifer, Moore, Justin X., Dent, Susan, Sutton, Arnethea L., Shanahan, John, Montero, Alberto J., Guha, Avirup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526347/
https://www.ncbi.nlm.nih.gov/pubmed/37760599
http://dx.doi.org/10.3390/cancers15184630
Descripción
Sumario:SIMPLE SUMMARY: This research aimed to investigate if adding social determinants of health (SDOH) to predictive models improves major adverse cardiovascular events (MACE) predictions in breast cancer patients, as cardiovascular disease is their leading cause of death. ML models, incorporating SDOH, demographics, risk factors, tumor characteristics, and treatments, were developed and compared. The results showed that including SDOH enhanced ML model performance in forecasting MACEs within two years of breast cancer diagnosis, especially for non-Hispanic Black patients. These findings offer more accurate risk assessments and personalized care insights for breast cancer patients, while also guiding efforts toward achieving healthcare equity. ABSTRACT: Cardiovascular disease is the leading cause of mortality among breast cancer (BC) patients aged 50 and above. Machine Learning (ML) models are increasingly utilized as prediction tools, and recent evidence suggests that incorporating social determinants of health (SDOH) data can enhance its performance. This study included females ≥ 18 years diagnosed with BC at any stage. The outcomes were the diagnosis and time-to-event of major adverse cardiovascular events (MACEs) within two years following a cancer diagnosis. Covariates encompassed demographics, risk factors, individual and neighborhood-level SDOH, tumor characteristics, and BC treatment. Race-specific and race-agnostic Extreme Gradient Boosting ML models with and without SDOH data were developed and compared based on their C-index. Among 4309 patients, 11.4% experienced a 2-year MACE. The race-agnostic models exhibited a C-index of 0.78 (95% CI 0.76–0.79) and 0.81 (95% CI 0.80–0.82) without and with SDOH data, respectively. In non-Hispanic Black women (NHB; n = 765), models without and with SDOH data achieved a C-index of 0.74 (95% CI 0.72–0.76) and 0.75 (95% CI 0.73–0.78), respectively. Among non-Hispanic White women (n = 3321), models without and with SDOH data yielded a C-index of 0.79 (95% CI 0.77–0.80) and 0.79 (95% CI 0.77–0.80), respectively. In summary, including SDOH data improves the predictive performance of ML models in forecasting 2-year MACE among BC females, particularly within NHB.